38.15
price down icon1.09%   -0.42
after-market Handel nachbörslich: 37.79 -0.36 -0.94%
loading

Finanzdaten der Exelixis Inc-Aktie (EXEL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-07-04 2025-04-04 2024-09-27 2024-06-28 2024-03-29
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.31%
568.26
555.45 539.54 637.18 425.23
Cost Of Revenue
1.55%
19.47
19.17 17.33 17.67 21.26
Gross Profit
2.33%
548.79
536.27 522.21 619.51 403.97
Operating Expenses
4.06%
335.21
349.42 386.14 343.64 374.51
Benefits Costs and Expenses
3.77%
354.69
368.59 403.47 361.30 395.76
Costs And Expenses
3.77%
354.69
368.59 403.47 361.30 395.76
Operating Income/Loss
14.30%
213.58
186.86 136.07 275.87 29.46
Income/Loss From Continuing Operations Before Tax
14.30%
213.58
186.86 136.07 275.87 29.46
Income Tax Expense/Benefit
1.10%
45.57
46.07 36.78 66.73 11.95
Income/Loss From Continuing Operations After Tax
15.81%
184.85
159.62 117.97 226.12 37.32
Net Income/Loss
15.81%
184.85
159.62 117.97 226.12 37.32
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2.23%
272.58
278.80 285.62 289.22 300.76
Diluted Average Shares
1.31%
284.39
288.18 291.48 293.97 305.53
Basic Earnings Per Share
19.30%
0.68
0.57 0.41 0.78 0.12
Diluted Earnings Per Share
18.18%
0.65
0.55 0.40 0.77 0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):